Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2

Status

Unknown 2Completed 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Other solid neoplasm 1

Conditions

Neoplasms 2Solid Tumors 1Advanced Cancer 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Interventional × indibulin × Clear all
NCT00591136 2012-07-19

Phase I Study of Indibulin in Patients With Solid Tumors

Alaunos Therapeutics

Phase 1 Completed
47 enrolled
Other solid neoplasm

Solid Tumors

NCT00591292 2012-07-19

Phase I Study in Advanced Solid Tumors

Alaunos Therapeutics

Phase 1 Unknown
22 enrolled
Tumor-Agnostic

Neoplasms

NCT00591383 2012-07-19

Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors

Alaunos Therapeutics

Phase 1 Unknown
10 enrolled
Tumor-Agnostic

Neoplasms

NCT00591890 2012-07-19

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

Alaunos Therapeutics

Phase 1 Completed
20 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡